UCB partners with Cradle on AI-driven antibody engineering
UCB•UCB entered a strategic collaboration with Cradle to expand its digital antibody discovery and engineering capabilities. Cradle’s AI-driven platform will support selected projects from hit generation through lead optimization and preclinical readiness.
1. Collaboration scope
UCB entered a strategic collaboration with Cradle. Cradle’s AI-driven protein engineering platform will support selected discovery projects from hit generation through lead optimization and preclinical readiness.
2. Drug discovery aims
The collaboration aims to accelerate the identification and optimization of high-quality drug candidates for severe diseases.
